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Ubiquitination and deubiquitination regulate several essential cellular processes such as protein
degradation, cell-cycle progression, signaling, and DNA repair. Given the importance of these
processes, it is not surprising that many microbes have developed the means to interfere with differ-
ent stages of ubiquitin pathways to promote their survival and replication. This review focuses on
virulence proteins of bacterial pathogens that mediate these effects and summarizes our current
understanding of their actions.Introduction
Small reversible posttranslational modifications of pro-
teins provide a widespread mechanism for regulating
a broad range of cellular processes, enabling cells to
respond rapidly to changes in their environment. Such
modifications include phosphorylation, acetylation, and
among eukaryotes, ubiquitination and ubiquitin-like mod-
ifications such as sumoylation and neddylation.
Ubiquitin (Ub) is a small protein of 76 amino acids
(Goldstein et al., 1975). It is present in all eukaryotes
and is highly conserved, with only three amino acid differ-
ences between the yeast and human proteins. Ubiquitina-
tion involves covalent addition of Ub monomers to lysine
residues of target proteins or of Ub itself (to form poly-Ub
chains), via the involvement of at least three enzymes:
a Ub-activating enzyme (E1), a Ub-conjugating enzyme
(E2), and a Ub ligase (E3) (Figure 1). E1 enzymes are re-
sponsible for the ATP-dependent activation of the C ter-
minus of Ub, which is then directed to the active site of
an E2 enzyme. E3 ligases (of which there are over 1000
encoded by human genome) are a large and diverse
group of proteins that have been subclassified by the
presence of different motifs, including HECT, RING, and
U box domains. HECT E3s transfer Ub from the E2 to
a thioester linkage on the E3, and then to the substrate,
while RING and U box E3s enable protein ubiquitination
by acting as adaptors that bind to E2 proteins and sub-
strates separately and facilitate direct transfer of Ub
from the E2 protein to the substrate. A fourth group of
E3 ligases, called the modulator of immune recognition
(MIR) family, comprises membrane-bound proteins
containing a specialized form of the RING finger, plant ho-
meodomain (PHD) (Coscoy and Ganem, 2003; Ohmura-
Hoshino et al., 2006).
Several RING E3s appear to act independently, but
others are components of larger multiprotein complexes.
A good example of the latter are the cullin RING Ub li-
gases. The C-terminal regions of cullin proteins interact
with the E2-interacting RING protein ROC-1. The N-termi-nal region of cullins interact with linker or adaptor proteins
such as SCF (Skp-1, Cul-1, F box), which in turn bind to
the substrate. Cullins are themselves positively regulated
by the binding of the small Ub-like protein (Ubl) neural pre-
cursor cell-expressed developmentally downregulated 8
(NEDD8) (RUB1 in S. cerevisiae).
In addition to NEDD8, other small proteins with various
degrees of sequence similarity to Ub have been identified
that link to proteins in an analogous manner to ubiquitina-
tion. These include small ubiquitin-like modifier 1
(SUMO-1) also known as Ubl1, Sentrin, or PIC-1 (Jentsch
and Pyrowolakis, 2000; Yeh et al., 2000). Sumoylation oc-
curs on a wide range of substrates including signaling
molecules and several transcriptional regulators (Muller
et al., 2001; Sapetschnig et al., 2002; Seeler and Dejean,
2001). SUMO can also act by blocking Ub attachment
sites (Hoege et al., 2002). A key distinction between
SUMO and Ub is the inability of SUMO to conjugate to it-
self (Pickart, 1997). The ability of Ub to interact with a wide
range of proteins, including itself, and to form a variety of
different length and linkages of chains, increases its ca-
pacity to manipulate a larger array of signals compared
to Ubls. For a comprehensive review of Ub and Ub-like
protein modifications, the reader is referred to a recent
review (Kerscher et al., 2006).
The fate of ubiquitinated proteins depends on the com-
bination of interacting E2 and E3 enzymes and the length
and linkage of the Ub chains. Chains of four or more Ub
molecules linked through lysine 48 (K48) of Ub target the
modified protein for proteasomal degradation (Thrower
et al., 2000). K63-linked polyubiquitin chains regulate
a wide range of important cellular processes such as
DNA repair, signaling, endocytosis, vesicular trafficking,
and cell-cycle progression (Haglund and Dikic, 2005;
Hicke and Dunn, 2003; Huang and D’Andrea, 2006).
Monoubiquitination (modification with one ubiquitin mole-
cule) controls subcellular protein localization, endocyto-
sis, and recruitment of Ub-binding proteins (Haglund
and Dikic, 2005).Cell Host & Microbe 1, March 2007 ª2007 Elsevier Inc. 13
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Protein ubiquitination is a reversible process, and Ub de-
conjugation, catalyzed by deubiquitinating enzymes
(DUBs), plays an important role in processing Ub precur-
sors, proofreading Ub protein conjugates, and removing
Ub from target proteins (Figure 1). Major progress has
been made in understanding pathways of ubiquitination,
but our understanding of the functions of DUBs is much
less advanced. DUBs are present in all eukaryotic cells,
and approximately 100 are predicted to be encoded by
the human genome. They include both metalloproteases
(JAMM/MPN+) and cysteine proteases, with the majority
being of the latter type. The cysteine protease DUBs
have been grouped into four different classes based on
their sequence and predicted activity: Ub-specific prote-
ases (USPs, also referred to as Ub processing proteases,
UBPs), Ub C-terminal hydrolases (UCHs), ovarian tumor-
related proteases/Cezanne (OTUs), and Josephin domain
proteases (JD) (Amerik and Hochstrasser, 2004; Nijman
et al., 2005; Sulea et al., 2006). USPs represent the most
diverse class, comprising proteases with two short con-
served motifs, the Cys and His boxes, flanked by N- and
C-terminal regions of differing length and sequence. The
UCH class contains small proteins originally identified by
their ability to hydrolyze small amides and esters at the
C terminus of Ub. The other classes have only been recog-
nized recently and contain only a fewmembers. Proteases
Figure 1. Schematic Figure of Ubiquitin Activation,
Conjugation, and Deconjugation
E1 enzymes activate the C terminus of ubiquitin in an ATP-dependent
manner, which directs ubiquitin to an E2 enzyme. E3 ligases transfer
ubiquitin either from the E2 to a thioester linkage on the E3, and then
to the substrate, or by acting as adaptors that bind to E2 proteins
and substrates separately, and facilitate direct transfer of Ub from
the E2 protein to the substrate. Chains of four or more Ub molecules
linked through lysine 48 (K48) of ubiquitin target the modified protein
for proteasomal degradation, whereas K63-linked polyubiquitin chains
regulate several cellular processes, such as DNA repair, signaling, en-
docytosis, vesicular trafficking, and cell-cycle progression. Ubiquitin
deconjugation is a reversible process catalyzed by deubiquitinating
enzymes (DUBs). These play an important role in processing Ub pre-
cursors, proofreading Ub protein conjugates, and removing Ub from
substrate proteins.14 Cell Host & Microbe 1, March 2007 ª2007 Elsevier Inc.have also been divided into families and clans according
to a hierarchical classification on the basis of degree of
similarity in amino acid sequence. Families of proteases
that are homologous are grouped together in a clan.
According to this system, cysteine proteases have been
divided into 9 clans and 47 families (http://merops.
sanger.ac.uk/index.htm). Several cysteine proteases that
are DUBs or Ub-like protein-specific proteases (ULPs)
have been classified into the clans CA and CE. In clan
CA, the Cys motif is N proximal to the His box, whereas
the reverse is the case in clan CE.
In contrast to many other proteases, which are trans-
lated as inactive precursors, DUBs are generally produced
as active enzymes, and structural analysis has revealed
that the catalytic triad only assumes the active conforma-
tion upon binding of Ub, thereby preventing nonspecific
protease activity (Nijman et al., 2005). Specificity of
DUBs is also likely to be determined by regions outside
the catalytic core of the enzyme, and both the target and
the attached Ub monomer or polymer are likely to be im-
portant for recognition by the DUB.
Bacterial Intervention
Studies on the interactions between bacteria and host
cells over the last decade have revealed a remarkable
diversity of cellular processes that are modulated by
Gram-positive and Gram-negative pathogens. Several
Gram-negative bacterial pathogens use type three secre-
tion (T3S) systems to deliver effector proteins into host
cells. Components of the T3S apparatus (which resembles
a needle-like structure in both form and function; Galan
and Wolf-Watz, 2006) are conserved in different patho-
gens; however, each pathogen is endowed with a unique
repertoire of effectors that contribute to the disease pro-
cesses caused by that pathogen. These effectors interfere
with the actin, microtubule, and intermediate filament cy-
toskeletons; microtubule motors; specific stages of the
endocytic and secretory pathways; and a host of signaling
pathways, affecting, for example, transcription, transla-
tion, cell division, cell migration, and immune responses.
Given the importance of ubiquitination and deubiquitina-
tion in the regulation of many cellular processes, it is not
surprising that pathogenic bacteria have developed the
means to interfere extensively with different stages of Ub
pathways. In this review we focus on the bacterial viru-
lence proteins that mediate these effects (summarized in
Table 1), and what is known of the mechanisms by which
they interfere with Ub pathways.
Yersinia YopJ/P
The first bacterial protein shown to have DUB activity was
the Yersinia T3S effector YopJ/P (referred to as YopJ in
Yersinia pseudotuberculosis and YopP in Yersinia entero-
colitica) (Figure 2). YopJ is present in all three Yersinia spp.
pathogenic for humans; these bacteria are mainly extra-
cellular pathogens causing both enteric diseases
(Y. pseudotuberculosis and Y. enterocolitica) and plague
(Y. pestis). YopJ plays an important role in inhibiting
the inflammatory response and inducing apoptosis in
Cell Host & Microbe
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Pathogen
Virulence
Protein
Biochemical
Function Target(s) Physiological Effect(s) Reference
C. trachomatis ChlaDub1 DUB and
deneddylator
unknown unknown Misaghi et al., 2006
ChlaDub2 DUB and
deneddylator
unknown unknown Misaghi et al., 2006
P. syringae AvrPtoB E3 ligase unknown suppression of plant
immunity
Janjusevic et al., 2006
S. Typhimurium SseL DUB unknown cytotoxicity Rytko¨nen et al., 2007
SopA E3 ligase induction of PMN trans-
epithelial migration
Zhang et al., 2006
S. flexneri OspG kinase Ub E2 molecules suppression of host
innate response
Kim et al., 2005
IpaH9.8 E3 ligase MAPKK Ste7
in yeast
suppression of
inflammatory response
Rohde et al., 2007;
Okuda et al., 2005
Yersinia YopJ/YopP DUB/acetyl-
transferase
unknown/MKKs
and IKKs
suppression of MAPK
and NF-kB pathway,
induction of apoptosis
Zhou et al., 2005;
Mukherjee et al., 2006;
Mittal et al., 2006
PMN, polymorphonuclear leukocytes.macrophages. By interfering with the NF-kB pathway
through inhibition of MAPK (mitogen-activated protein
kinase) kinases and IKKb, YopJ suppresses proinflam-
matory signaling via TNF and IL-8 production, as well as
inducing apoptosis (Boland and Cornelis, 1998; Mills
et al., 1997; Monack et al., 1997; Orth et al., 1999; Palmer
et al., 1998; Yoon et al., 2003; Zhou et al., 2004). YopJ is
amember of clan CE, family 55, and its substrate was orig-
inally thought to be SUMO-1, since expression of YopJ in
mammalian cells decreased the cellular concentration of
SUMO-1-conjugated proteins (Orth et al., 2000). How-
ever, a subsequent study showed that purified YopJ
cleaves Ub-amino methyl coumarin (Ub-AMC) (a fluoro-
genic Ub conjugate) but not SUMO-1-AMC in vitro (Zhou
et al., 2005). Furthermore, infection of macrophages with
a Y. pseudotuberculosis strain expressing a mutant ver-
sion of YopJ in which the catalytic cysteine was replaced
by alanine resulted in the accumulation of ubiquitinated
IkBa in the macrophage cytosol (Zhou et al., 2005). Nor-
mally, activation of the NF-kB pathway leads to phosphor-
ylation, ubiquitination, and proteasomal degradation of
IkBa, which allows the translocation of NF-kB to the nu-
cleus, where it regulates transcription of genes involved
in proinflammatory signaling. Translocated YopJ was
therefore proposed to act as a DUB for ubiquitinated
IkBa, thereby preventing its degradation. However, YopJ
is evidently not able to hydrolyze ubiquitinated IkBa in vitro
(Collier-Hyams et al., 2002). Furthermore, it has been
shown recently by two groups that YopJ can function as
an acetyltransferase in vitro by transferring acetyl groups
to serine and threonine residues in the activation loop of
MAPKK6, effectively preventing their phosphorylation
and hence kinase activation (Bliska, 2006; Mittal et al.,
2006; Mukherjee et al., 2006). It is important to know ifYopJ can cause similar modifications in vivo, since it is
not immediately obvious how a loss of acetyltransferase
activity on MAPKK6 would result in an accumulation of
ubiquitinated IkBa in infected cells (Zhou et al., 2005).
However, these studies raise the possibility that YopJ is
a bifunctional enzyme that acetylates one or more sub-
strate and deubiquitinates another. Such relaxed sub-
strate specificity of a bacterial enzyme would not be
unprecedented: E. coli TAP is a multifunctional enzyme
that has both protease and deacetylating activities (Lee
et al., 2006).
Salmonella
Salmonella enterica serovar Typhimurium is an invasive
pathogen that colonizes the small intestine, and in themu-
rinemodel of typhoid it penetrates the epithelium and tran-
sits from Peyer’s patches and mesenteric lymph nodes to
the spleen and liver, where it replicates in macrophages.
Following invasion or phagocytosis by macrophages,
the vast majority of intracellular S. enterica remain in
a membrane-bound compartment, the Salmonella-
containing vacuole (SCV), which the bacteria modify to
provide an environment favorable for replication. To in-
vade host cells, Salmonella uses a T3S system encoded
by the Salmonella pathogenicity island 1 (SPI-1). This sys-
tem translocates several effector proteins across the host-
cell plasma membrane. Some of these remodel the actin
cytoskeleton to cause localized membrane ruffling and
bacterial uptake. Thereafter, another set of effectors is
translocated across the vacuolar membrane. This is ac-
complished by the T3S system encoded by SPI-2, which
translocates over 20 effectors, detectable approximately
4 hr following entry of bacteria. Together, these effector
proteins enable bacterial replication in a variety ofCell Host & Microbe 1, March 2007 ª2007 Elsevier Inc. 15
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YopJ/P, a Yersinia T3S effector protein with DUB and acetyltransferase activity, is translocated into host cells, where it interferes with the NF-kB path-
way through inhibition of MKKs (mitogen-activated protein kinase kinases) and IKKb and possibly by deubiquitinating ubiquitinated IkB-a. YopJ plays
an important role in inhibiting the inflammatory response and induces apoptosis in macrophages. Shigella also inhibits host immune responses. Fol-
lowing translocation into host cells, OspG acts as a kinase and blocks TNF-induced IkBa degradation, conceivably by phosphorylating a component
of SCFb-TrCP complex. IpaH9.8, another Shigella effector, functions as an E3 Ub ligase that interferes with the pheromone response signaling pathway
in yeast by ubiquitinating the MAPKK Ste7. To facilitate invasion and intracellular survival, Salmonella translocates two sets of effector proteins into
the host cells. The Salmonella pathogenicity island 1 (SPI-1) T3S system translocates effector proteins across the host-cell plasma membrane.
Several of these effectors are ubiquitinated following translocation, but one, SopA, functions as a HECT-like E3 Ub ligase that preferentially uses
the inflammation-associated E2s UbcH5a, UbcH5c, and UbcH7 for ubiquitination in vitro. SopA induces a host inflammatory response by promoting
polymorphonuclear leukocyte transepithelial migration. Following uptake, Salmonella translocates another set of effectors across the Salmonella-
containing vacuole via the SPI-2 T3S system. SseL is translocated approximately 6 hr postuptake and acts as a DUB in vivo to trigger a delayed
cytotoxic effect in macrophages.host-cell types and also induce a delayed cytotoxicity in
macrophages (Kuhle and Hensel, 2004; Waterman and
Holden, 2003).
Salmonellae that are both pathogenic and nonpatho-
genic for humans interfere with ubiquitination pathways.
Whereas pathogenic Salmonella elicits an NF-kB-depen-
dent proinflammatory response upon colonization of
human intestinal epithelial cells in vitro, nonpathogenic
strains are capable of suppressing this response. The inhi-
bition does not affect the phosphorylation of IkBa but
somehow affects its subsequent ubiquitination, and
thereby prevents its degradation (Neish et al., 2000). The
inhibition appears to be specific to the E3-SCFb-TrCP sub-
strates IkBa and b-catenin and caused by a rapid loss of
neddylated Cullin-1, which is a subunit of the E3-SCF
complex necessary for ubiquitination of IkBa and subse-
quent activation of NF-kB (Collier-Hyams et al., 2005).
The Salmonella molecule(s) responsible and the mecha-
nisms involved in this interesting activity are not yet known.
AvrA is predicted to be a clan CE protein translocated
by the SPI-1 T3S system in a subset of strains of S. enter-
ica (Hardt and Galan, 1997). AvrA has 56% identity to
YopJ and also inhibits the NF-kB pathway. However,
this seems to occur at a different stage than YopJ,
because in transfected cells YopJ had little effect on16 Cell Host & Microbe 1, March 2007 ª2007 Elsevier Inc.NF-kB-dependent reporter gene activity when cells were
stimulated with IKK-b, whereas AvrA effectively inhibited
reporter gene activity (Collier-Hyams et al., 2002). How-
ever, like YopJ, AvrA contributes to apoptosis of host cells
(Collier-Hyams et al., 2002). While the inhibitory activity of
AvrA on the NF-kB pathway was shown to be dependent
on a putative catalytic cysteine, it has yet to be established
if AvrA is a DUB.
Several other effectors involved in Salmonella invasion
are either ubiquitinated or modulate ubiquitination follow-
ing their translocation to the host cells. SopE is a guanine
nucleotide exchange factor for Rac1 that stimulates the
actin polymerization required for membrane ruffling and
bacterial uptake (Patel and Galan, 2006). SptP, which is
codelivered into host cells in similar quantities to SopE,
acts as a GTPase-activating protein and counteracts the
activity of SopE (Fu and Galan, 1999). SopE is rapidly
ubiquitinated and degraded, while the half-life of SptP is
much longer. Domain-swapping experiments revealed
that differential degradation kinetics is controlled by infor-
mation in the N-terminal secretion and translocation do-
mains of these proteins. The differential half-life of these
proteins therefore accounts for the transient nature of
the ruffling response induced by Salmonella (Kubori and
Galan, 2003).
Cell Host & Microbe 1, March 2007 ª2007 Elsevier Inc. 17
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role in the induction of host inflammatory responses by
promoting polymorphonuclear (PMN) leukocyte transepi-
thelial migration (Wood et al., 2000) (Figure 2). In epithelial
cells, translocated SopA is ubiquitinated by an E3 ligase,
HsRMA1, and subsequently degraded. While the majority
of S. enterica serovar Typhimurium (S. Typhimurium) bac-
teria remain within membrane-bound vacuoles, a small
proportion escape into the epithelial cell cytosol, where
they replicate. Ubiquitinated SopA appears to have a mi-
nor role in promoting vacuolar escape, since mutation of
sopA or RNAi of HsRMA1 reduced the numbers of bacte-
ria that escaped their vacuoles (Zhang et al., 2005). In
macrophages, cytosolic bacteria fail to replicate (Beuzon
et al., 2002) and become surrounded by polyubiquitinated
proteins and proteasomes, which might contribute to
bacterial growth suppression (Perrin et al., 2004). Remark-
ably, recent work has shown that SopA is itself a HECT-
like E3 Ub ligase (Zhang et al., 2006). Consistent with a
regulatory role in inflammation, SopA preferentially used
the inflammation-associated E2s UbcH5a, UbcH5c, and
UbcH7 for ubiquitination in vitro, and a Salmonella strain
expressing an E3 ligase-dead point mutant version of
SopA induced less PMN transepithelial migration in vitro
(Zhang et al., 2006). SopA could ubiquitinate bacterially
derived or host proteins (or both), and identification of its
physiological target(s) is now crucial in understanding its
role in inflammation and enteritis.
SigD/SopB is a fourth SPI-1 effector that is ubiquiti-
nated upon translocation to the host cell. This inositol
phosphatase localizes to the surface of the nascent
SCV, where it persists for several hours (Marcus et al.,
2002). It acts by retaining high levels of phosphatidylinosi-
tol-3-phosphate [PtdIns(3)P] in the SCV membrane and
has important roles in bacterial replication (Galan and
Collmer, 1999; Hernandez et al., 2004) and suppression
of apoptosis in epithelial cells by activation of Akt (Knodler
et al., 2005), and membrane fission during bacterial inva-
sion (Terebiznik et al., 2002). By 2 hr postinvasion, ubiqui-
tin-conjugated SigD/SopB can be detected, but curiously
this does not appear to lead to its degradation by the pro-
teasome (Marcus et al., 2002), and the functional signifi-
cance of its ubiquitination (if any) is not understood.
Interferencewith ubiquitination bySalmonella continues
after the expression of the SPI-2 T3S system. SseL is
a newly characterized effector of cysteine protease clan
CE whose translocation onto the vacuolar membrane
can be detected in epithelial cells and macrophages after
approximately 6 hr following uptake of bacteria (Rytko¨nen
et al., 2007) (Figure 2). A yeast two-hybrid screen with
SseL and a HeLa cell cDNA library revealed that SseL in-
teracts directly with Ub. A purified GST-SseL fusion pro-
tein specifically cleaved ubiquitin substrates, and infection
of epithelial cells and macrophages with S. Typhimurium
sseL mutant strains led to the accumulation of ubiquitin-
modified proteins, indicating that SseL functions as
a DUB in vivo. However, unlike YopJ, SseL did not influ-
ence cytokine production or interfere with activation or
degradation of IkBa upon infection of macrophages.sseLmutant strains did not display an intracellular replica-
tion defect but were defective for a SPI-2-dependent late-
stage cytotoxic effect on macrophages and were attenu-
ated for virulence in the systemic phase of infection in
mice (Rytko¨nen et al., 2007). This shows that ubiquitinated
proteins of host or bacterial origin accumulate on (or in
close proximity to) the SCVmembrane, and these are deu-
biquitinated by SseL. How this leads to cytotoxicity re-
mains to be established, but the study provides evidence
that the cytotoxic activity of Salmonella is an important
component of its virulence. It is tempting to speculate
that the deubiquitinating activity of SseL might function
to counteract ubiquitination and degradation of other
translocated bacterial effectors by the host-cell machin-
ery. However, this seems unlikely for two reasons. First,
an important collective function of SPI-2 T3S system ef-
fectors is to enable intracellular growth (Waterman and
Holden, 2003) and if SseL acted by protecting these effec-
tors then an sseL mutant would be predicted to have an
intracellular replication defect. Secondly, SseL has a
clear preference for K63-linked Ub chains (Rytko¨nen
et al., 2007), indicating that it is likely to be involved in sig-
naling events rather than interfering directly with protein
degradation.
Shigella
Shigella flexneri is an important cause of human bacillary
dysentery. The morphological features of Shigella entry
into epithelial cells are similar to those induced by
S. Typhimurium, and although both require T3S systems,
the effector protein repertoire and infection process fol-
lowing invasion are distinct. S. flexneri invades the colonic
epithelium initially through M cells of Peyer’s patches.
Bacteria then interact with macrophages in the lymphoid
follicle, and enterocytes via their basolateral membranes.
These interactions result in a strong proinflammatory re-
sponse that exacerbates infection of the intestinal epithe-
lium. However, it has become clear that stimulation of
proinflammatory responses is subsequently modulated
by the action of several bacterial effectors (Arbibe et al.,
2007; Kim et al., 2005). OspG is one of approximately 20
effectors delivered to the host cells by the Shigella T3S
system. A yeast two-hybrid screen showed that OspG
interacts with ubiquitinylated E2 molecules, including
UbcH5b (Figure 2). OspGwas shown to have kinase activ-
ity but evidently does not phosphorylate E2 proteins. Nev-
ertheless, OspG can block TNF-induced IkBa degrada-
tion, a process that is dependent on UbcH5b (Kim et al.,
2005). This effect requires a lysine residue important for
kinase activity of OspG and suggests that OspG acts at
the step of phospho-IkBa ubiquitination. Possibly, OspG
acts by phosphorylating a component of SCFb-TrCP in the
context of OspG-UbcH5b. The biochemical evidence for
dampening of the inflammatory response is supported
by the phenotype of an ospG mutant, which induced
a much stronger inflammatory response during infection
of rabbit ileal loops (Kim et al., 2005).
IpaH9.8 is another effector delivered by Shigella into
host cells, where it translocates to the nucleus (Haraga
Cell Host & Microbe
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been shown that IpaH9.8 is an E3 Ub ligase (Rohde
et al., 2007) (Figure 2). Its biochemical characterization
was achieved by using Saccharomyces both as a host
for an initial phenotypic screen, and then to identify its tar-
get and biochemical function. IpaH9.8 was shown to inter-
fere with the pheromone response signaling pathway by
ubiquitinating the MAPKK Ste7, which leads to its protea-
some-dependent destruction (Rohde et al., 2007). Work
from another group has shown that, in mammalian cells,
IpaH9.8 interacts with U2AF35—a component of an essen-
tial pre-mRNA splicing factor complex (Okuda et al.,
2005). Deletion of ipaH9.8 resulted in increased proinflam-
matory cytokine production and, consistent with the hy-
pothesis that IpaH9.8 might interfere with the function of
U2AF35, reduction of U2AF35 expression by siRNA-medi-
ated knockdown caused a decrease in the expression of
these cytokines (Okuda et al., 2005). It would be interest-
ing to know if IpaH9.8 can ubiquitinate U2AF35, which
might help to reconcile the results from these two studies.
The finding that IpaH9.8 is an E3 ligase has broader impli-
cations, since homologous proteins with similar domain
organization and containing a critical cysteine residue
are found not only in Shigella but also in several other bac-
terial pathogens. These proteins include Salmonella
SspH1, an effector of both the SPI-1 and SPI-2 T3S sys-
tems. Purified SspH1 was shown to have E3 ligase activity
on PKN1 (Rohde et al., 2007), a host-cell kinase previously
shown to interact with SspH1 (Haraga and Miller, 2006).
Chlamydia
The availability of ubiquitin-based probes has provided
useful reagents to identify new DUBs from mammalian
cells and viruses (Galardy et al., 2005; Ovaa et al., 2005).
Recently, this approach was used to identify two DUBs
fromChlamydia trachomatis (Misaghi et al., 2006). Lysates
of infected HeLa cells were incubated with an epitope-
tagged Ub-vinylmethylester conjugate, which forms a co-
valent adduct with the active site cysteine of DUBs (Boro-
dovsky et al., 2001). Following immunoprecipitation, an
interacting protein was fractionated by SDS-PAGE and
identified bymass spectrometry. Genome sequence anal-
ysis revealed that the gene encoding this DUB is flanked
by a homolog. Both corresponding proteins (named Chla-
Dub1 andChlaDub2) were shown to have deubiquitinating
and deneddylating activities. AlthoughChlaDub1 is clearly
translocated into host cells by bacteria, its localization,
biochemical target(s), and possible role during infection
remain to be established.
Escherichia coli
CNF1 toxin is produced by uropathogenic E. coli, and re-
lated toxins have been found in Y. pseudotuberculosis and
Bordetella pertussis. The toxin is taken up by mammalian
cells by endocytosis and then passes into the cytosol by
translocation through the endosomal membrane (Boquet,
2001). CNF1 functions by deamidating a specific gluta-
mine residue of Rho GTPases to glutamate. This prevents
endogenous or induced GTPase activity of these molecu-18 Cell Host & Microbe 1, March 2007 ª2007 Elsevier Inc.lar switches, effectively locking them into a permanently
active state. However, this effect is only transient, as the
host cell responds by depleting the modified GTPases
by ubiquitination and proteasome-mediated degradation
(Doye et al., 2002). Hence, although the immediate effect
of CNF1 deamidation of Rho proteins is their activation,
the long-term consequence is ubiquitination and degrada-
tion. In the case of RhoA, this is carried out by an E3 ligase
called Smurf1 (Boyer et al., 2006).
Listeria
Listeria monocytogenes is a Gram-positive bacterial path-
ogen that interacts with host-cell surface proteins to trig-
ger signaling pathways leading to bacterial uptake. One
such pathway involves a bacterial cell surface-localized
protein, InlB, and the growth factor receptor Met (Shen
et al., 2000). Interaction between Met and its ligand nor-
mally triggers the recruitment of the Ub ligase Cbl, which
ubiquitinates Met and leads to its endocytosis. It was
found recently that InlB can mediate the same process,
and furthermore that the Ub-dependent endocytosis ma-
chinery is required for internalization of bacteria (Veiga and
Cossart, 2005). While the interaction between InlB and
ubiquitination machinery is indirect, this discovery reveals
another means by which bacterial pathogens harness
host Ub-dependent pathways to promote their virulence.
Following uptake into host cells, L. monocytogenes es-
capes its vacuole and begins to replicate and spread in
the host-cell cytosol. This is dependent on the action of
the secreted cytolysin listeriolysin O (LLO). LLO is poten-
tially damaging to the host-cell plasma membrane, and
to ensure that bacteria remain intracellular, the activity of
LLO must be restricted to the vacuolar membrane. By
mechanisms that are still unclear, LLO is rapidly ubiquiti-
nated and degraded by the proteasome machinery
(Schnupf et al., 2006).
Plant Pathogens
Bacterial plant pathogens also use specialized secretion
systems to deliver effector proteins into host cells. As
with animal pathogens, the processes of activation, conju-
gation, and deconjugation of Ub and Ubls all appear to be
targeted by bacterial effector proteins. VirF of Agrobacte-
rium is one of several proteins involved in transfer of
T-DNA from this bacterium into plant cells. It localizes to
the plant cell nucleus, where it causes the degradation
of a plant protein VIP1. This is thought to be mediated
by an F box motif in VirF that binds the plant homolog of
Skp1, a component of SCF in some E3 ligase complexes
(Tzfira et al., 2004). AvrPtoB is a T3S effector translocated
into tomato cells by Pseudomonas syringae, where it
inhibits hypersensitivity—a plant immune response involv-
ing rapid localized host-cell death at the site of infection.
The amino acid sequence of AvrPtoB provided no infor-
mation as to its function, but the crystal structure of the
C-terminal domain of AvrPtoB revealed striking similarity
to U box and RING finger components of E3 ligases (Jan-
jusevic et al., 2006). Purified AvrPtoB was shown to have
E3 ligase activity in vitro, and putative E2 binding site
Cell Host & Microbe
Reviewresidues were shown to be critical for suppression of the
plant hypersensitive response (Janjusevic et al., 2006).
Presumably, AvrPtoB recruits E2 partners and substrates
and transfers Ub to host-cell proteins(s) that positively
regulate the plant defense response. However, the cellular
substrate(s) of this activity have not yet been identified.
Xanthomonas campestris is a related pathogen of solana-
ceous plants; one of its T3S system effectors, XopD, has
been characterized as a cysteine protease of clan CE,
family 48. This effector localizes to the plant cell nucleus,
where it cleaves (as yet uncharacterized) sumoylated pro-
teins (Hotson et al., 2003). XopD appears to have a strict
preference for plant SUMOs and was recently used to ob-
tain insight into substrate specificity of ULPs (Chosed
et al., 2007). Several other bacterial plant pathogens and
symbionts are predicted to contain proteins that have
been classified as members of clan CE, family 48 prote-
ases. These include Acidovorax avenae, Bradyrhizobium
japonicum,Mesorhizobium loti, and Rhizobium legumino-
sarum (http://merops.sanger.ac.uk/index.htm).
Viral Intervention
Although this review focuses on bacteria, several viruses
are also known to interfere with different steps in the ubiq-
uitin pathway. Some encode proteins that modify cullin-
like RING Ub ligases by interacting with substrate adap-
tors, redirecting the Ub ligase complex to new targets,
or protecting cellular proteins from ubiquitination (Barry
and Fruh, 2006). Both the Herpes and Poxvirus families
encode proteins with E3 ligase activity. These E3 ligases
promote ubiquitination of MHC-1, B7.2, ICAM-1, and
CD4, resulting in removal of these cell surface molecules
and obstruction of host immune responses (Coscoy
et al., 2001; Duncan et al., 2006; Hewitt et al., 2002; Man-
souri et al., 2003). Other viruses produce E3 ligases that
interfere with apoptosis and interferon (IFN) production
(Halford et al., 2006; Melroe et al., 2004; Taylor and Barry,
2006). Recently, it has become clear that some viruses, in-
cluding herpesvirus, cytomegalovirus, adenovirus, and
coronaviruses also encode DUBs; however, the targets
for most of these DUBs have not yet been identified (Kat-
tenhorn et al., 2005; Balakirev et al., 2002; Barretto et al.,
2005; Sulea et al., 2006; Wang et al., 2006).
Conclusions
From the work reviewed above and elsewhere (Boyer and
Lemichez, 2004; Angot et al., 2007), it is clear that inter-
ference of ubiquitination and deubiquitination plays an
important role in the virulence of several bacterial patho-
gens and frequently influences host immune responses.
Although the current list of bacterial effectors involved in
these processes is relatively short, they would appear to
fall into three general categories: those that act directly
on pathways by ‘‘mimicking’’ host-cell proteins (e.g., E3
ligases and DUBs), those that act indirectly (e.g., E. coli
CNF1 and Shigella OspG), and those that are themselves
subject to ubiquitination in ways that influence bacterial
virulence (e.g., Salmonella SopE). Much of our (albeit lim-
ited) understanding of this aspect of bacterial virulencehas been gained in the last few years, and it therefore
seems likely that the number of bacterial proteins that
either mimic or modulate host-cell proteins involved in
Ub pathways will increase considerably in the future. Of
the bacterial DUBs that have been identified to date,
none have the same architecture as the ‘‘classic’’ eukary-
otic DUBs (clan CA); they are all members of clan CE
proteases. As our knowledge of the clan organization of
DUBs and ULPs increases (Hotson and Mudgett, 2004),
it will become easier to identify putative new Ub- or ULP-
specific proteases among both plant and animal patho-
gens. However, identifying newmodifiers of the Ub conju-
gation machinery is unlikely to be straightforward, since
the bacterial E3 ligases identified to date do not display
striking amino acid sequence similarities, either between
themselves or with their mammalian counterparts. Amajor
problem is that the targets of most of these bacterial
effectors are currently unknown, and identifying them
can be fraught with difficulty: many of these effectors are
very potent, are produced transiently, and localize to spe-
cific regions of the infected cell. Specificity could therefore
be achieved by precise spatiotemporal control of effector
delivery rather than being an intrinsic property of the effec-
tors. The controversial literature regarding the function of
YopJ emphasizes the need for careful biochemical analy-
sis of putative cysteine proteases to reveal their physiolog-
ical functions in vivo. Ideally, this involves the study of the
protein in the natural context of infection, as opposed to
analysis following its overexpression either in vitro or
in vivo, but obviously this is not feasible in many instances.
Notwithstanding these concerns, the growing literature
on bacterial manipulation of Ub pathways reflects a very
important and widespread aspect of bacterial pathogene-
sis, and future research in this area will provide exciting
new insights into the mechanisms underlying bacterial
virulence.
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